Confirmatory Study for AD-810N in Patients with Parkinsonism in Dementia with Lewy Bodies.
Phase 3
- Conditions
- Parkinsonism in Dementia with Lewy Bodies
- Registration Number
- JPRN-jRCT2080222787
- Lead Sponsor
- Sumitomo Dainippon Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Patients met the diagnostic criteria of probable DLB
- Outpatients
- Patients taking L-DOPA/DCI in succession more than 12 weeks
etc.
Exclusion Criteria
- Patients with parkinsonism excepting Dementia with Lewy Bodies
- Patients with Parkinson's disease with dementia
- Epileptic patients
- Patients treated with zonisamide
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method